Last updated on September 2016

Coroflex ISAR 2000 Extended Registry (ISAR2000 Extended)


Brief description of study

Postmarket surveillance in terms of the safety and efficacy of Sirolimus-eluting Coroflex ISAR Stent for the treatment of "real world" patients with de-novo and restenotic lesions after stand-alone angioplasty in coronary arteries.

Detailed Study Description

The aim of the study is to assess the safety and efficacy of elective deployment of the Sirolimus-eluting Coroflex ISAR Stent for the treatment of "real world" de-novo and restenotic lesions after stand-alone angioplasty in coronary arteries of 2.0 mm up to 4.0 mm in diameter and up to 30 mm in length for procedural success and preservation of vessel patency.

Clinical Study Identifier: NCT02905214

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Florian Krackhardt, MD

Charit University Hospital
Berlin, Germany
  Connect »